Filed by newsfilecorp.com Lexaria Continues Transformation Into Alternative Health Sector KELOWNA, BC

Lexaria Continues Transformation Into Alternative Health

KELOWNA, BC November 12, 2014 - Lexaria Corp. (OTCQB: LXRP)

(CSE: LXX) (the "Company" or "Lexaria") announces has entered an agreement and

has begun a staged acquisition of a corporation and its expertise in delivering

Cannabidiol (CBD)-infused products. This marks a major milestone for Lexaria as

it is both our first foray into the United States based on a product derived

from legal industrial hemp; and it is also Lexaria s first step into the large

alternative health and wellness sector.

Lexaria has initially acquired 51% of PoViva Corp, and can

ultimately acquire up to 75% of the company through staged transactions. PoViva

literally means Taking in Life PoViva uses a patent pending process to bind

active CBD ingredients with a lipid, allowing for a more efficient and

comforting delivery of the CBD than competing products that do not have the

benefit of our patent-pending process.

PoViva owns two patents pending that govern the process used to

infuse the CBD into food products, and both patents pending are part of the

acquisition. An initial cash payment has been made to PoViva and Lexaria

currently has sufficient cash resources to completely fund and launch the

acquisition. Lexaria does not require any equity financing to complete the

Founder of PoViva, Ms. Marian Washington lends her extensive

leadership and knowledge of athletic physiology to the company. Marion has

Master s Degree in Biodynamics and Administration and was awarded an honorary

doctorate from West Chester State College. For thirty years, Marian served as

head women s basketball coach of prominent division one university. Ms.

Washington has been received into multiple Halls of Fame, received prominent

athletic leadership awards, and coached national and international teams,

including coaching the 1996 Olympic Women's Basketball Team to a gold medal.

Michelle Reillo, PhD, the co-founder of PoViva and will drive

production and new products within PoViva as the Product and Research Manager.

Michelle has a BSc in Nursing; a MS in Gerontology; and a PhD in Education. She

has extensive experience with both Federal and private proposal development and

submission and research projects, including CDC, NIH, NCI, NIDA, and AmFar. She

is a former Clinical Director of Hyperbaric Medical Clinic. Michelle is the

author of AIDS Under Pressure and pioneered retroviral research in hyperbaric

medicine and HIV/AIDS. She is the author of many highly regarded research papers

in the medical community.

Lexaria will strive to make its name synonymous with

rejuvenation and healthy living. Lexaria believes that feelings of good health

are a luxury to be enjoyed by all and will introduce products aimed to provide

comfort and well-being. We are currently conducting our investigation of

entering several popular food and drink sectors where our patent-pending

cannabidiol delivery might prove particularly popular. Lexaria will announce

further developments as our product mix becomes finalized.

To begin, we expect to launch PoViva Teas as our first

CBD-infused product using our patent-pending processes as quickly as possible.

According to the Tea Association of the USA Inc, Americans consumed over 79

billion servings of tea in 2012, its popularity far outstripping any alternative

health sector. On any given day, over 150 million Americans consume tea, and 84%

of all tea consumed is black tea.

Globally, tea is the most widely consumed beverage in the world

after water, with over 3 billion servings of tea per day. As part of the current

business agreement, Lexaria has acquired a 3-year exclusive right to the

patent-pending process to infuse CBD s into all global markets outside of the

USA. We will investigate all global initiatives that build and promote the

PoViva by Lexaria brand.

For example, the combined hot beverage markets of coffee and

tea together, globally, is $69.77 Billion expected in 2015, according to a 2010

report by Basu Majumder A., Bera B. and Rajan A.

Lexaria is beginning construction of an e-commerce website that

will allow for direct online sales of PoViva teas and other products across the

United States. Other sales channels, both domestic and international will also

be pursued and developed as rapidly as possible. Pre-orders for PoViva Tea by

Lexaria will be accepted soon.

Tea naturally contains no sodium and virtually no calories but

does contain flavonoids which are naturally occurring compounds thought to have

antioxidant properties. PoViva Tea by Lexaria will include non-psychoactive CBD

compounds through our patent pending process. Studies have shown that persons

who drink 3 or more cups of black tea per day, have a reduced risk of heart

disease and stroke. (1) Various studies have shown that drinking tea

can reduce the incidence of contracting cancers such as prostate, rectal, colon,

and squamous cell carcinoma. (2) Other research has found that

consuming antioxidants, such as those that are found in tea and in CBD s, may

result in a 69% lower likelihood of developing Parkinson s

Lexaria wishes to inform all stakeholders that it continues to

pursue its Health Canada MMPR Licensed Producer status by way of its joint

venture in Burlington Ontario with Enertopia Corp. Our goal of acquiring that

license remains unchanged. However, in light of delays in the licensing process outside of our control, we continue to pursue opportunities to build shareholder value as functionally and rapidly as possible.

Lexaria will be announcing additional information on its product mix and business plan in the immediate future. Our goal is to begin producing cash flows from these initiatives as soon as possible; focused on the immediate opportunities in the

CBD-sectors derived from already-legal hemp.

(1) Larsson SC, Virtamo J, Wolk A. Black tea consumption and risk of stroke in women and men. Ann Epidemiol. 2013 Mar; 23(3):157-60. (and Others)

(2) Su LJ, Arab L. Tea consumption and the reduced risk of colon cancer -- results from a national prospective cohort study. Public Health Nutr. 2002 Jun; 5(3): 419-25. (and Others)

(3) Hu G, Bidel S, et al. Coffee and tea consumption and the risk of Parkinson s disease. Mov Disord. 2007 Aug 21: [Epub ahead of print]

Lexaria's shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations,

cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as "anticipate," "if,"

"believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company's best judgment based upon

current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may

not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining

growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company's public announcements and filings. There is no assurance that the medical marijuana or alternative health

businesses will provide any benefit to Lexaria. There is no assurance that PoViva Teas will be accepted into the marketplace or have any positive impact upon Lexaria Corp. There is no assurance that PoViva Teas will promote, assist, or maintain any

beneficial human health conditions whatsoever.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.